11 APR 2024 · https://www.linkedin.com/in/joseph-allen-653b7415?challengeId=AQHta2L1g-_oVAAAAY3qI9-ABoqlfXDhYCfBgEMk-QYWVNdBgjvnygPKGPrhbApvSlayo6tZvzsiyNmtPIfTJOQLqqCzaZv4-Q&submissionId=5939c4c6-f1b1-b717-0db6-209df587d55e&challengeSource=AgGAVdzQ7-NDgwAAAY3qI-1JQC4kmcR2Q8xBCg35HKJ1uUfNqTtiyAUgNKGUB_4&challegeType=AgF1PyvqlgxteAAAAY3qI-1MAp5CUs0Dv2Ih0TUvhAJeQadoGlG2ZQs&memberId=AgFrt7sIyiS1uwAAAY3qI-1PifutzHcC_RoXlHW-Xx-qewA&recognizeDevice=AgHLalLSJ0gRnQAAAY3qI-1SZyahe1nmIofJ-aJUsAuliLguYgTi, Executive Director of https://bayhdolecoalition.org/, was at the forefront of the Bayh-Dole Act back in December 1980, which allowed researchers to own inventions resulting from federally funded research. However, 43 years later, the March-In Rights framework proposed by the Biden administration threatens to weaken America’s innovation. In this episode, Joe delves into the potential implications of this framework on drug pricing, the pipeline, and overall innovation. Join us as we discuss: - The significance of the Bayh-Dole Act and intellectual property in transforming how America drives innovation. - Why public-private partnerships and collaboration in the medical field are key for funding research projects. - The implications of enacting March-In Rights on the drug development pipeline

13 SEP 2023 · How can we create better outcomes for cancer patients? That’s the big goal https://www.linkedin.com/in/mohitmanrao/ is aiming for in his work as SVP & Head of US Oncology at https://www.astrazeneca.com/. In this episode, Mohit shares his perspective on the future of oncology and the pursuit of patient-centric care in a post-Inflation Reduction Act world. Join us as we discuss: - AstraZeneca's goal of launching 15 new drugs by 2030 - Solving for disparities in care and improving health equity - Timeline for drug development and its effect on patient outcomes

23 AUG 2023 · Can we create a future healthcare system that is accessible and affordable for all patients? That’s the major question that https://www.linkedin.com/in/mary-grealy-878a1b4/, CEO of Healthcare Leadership Council, is trying to answer through her work. Mary, a former speech pathologist turned lawyer, shares insights from her unique journey from the healthcare field to advocating for patient-centered, value-based healthcare systems. In this wide-ranging conversation, Mary shares the challenges faced in the industry but also her hope for a future where patients are empowered through collaboration and innovation. Join us as we discuss: - Why collaboration between stakeholders is key - Practical tips for advocates to make a compelling case to Congress - The potential effects of the new price-setting system - The impact of proposed legislation on treatments and cures

11 MAY 2023 · With recent movement in healthcare including President Biden’s Cancer Moonshot and the Inflation Reduction Act, one thing is clear: American healthcare is at a crossroads. As we begin to tackle the conversation of healthcare reform, how can we rebuild the system around patients? In this episode, https://www.linkedin.com/in/mjimeson/, Executive Director of https://accessandaffordability.org/, joins the show to explain how the system was never designed for patients, the benefits of a patient-centric system, and what the future holds for the industry. Join us as we discuss: - Why patient-centricity is notably absent in our healthcare system - MacKay’s op-ed in response to President Biden’s SOTU - The impact of The Inflation Reduction Act and Centers for Medicare & Medicaid Services on today’s healthcare landscape - The true human impact of medicines MacKay’s Op-Ed: https://www.statnews.com/2023/02/09/state-of-the-union-highlights-americas-awkward-conversation-on-science-medicine-and-financing-the-development-of-new-medicines/ MacKay’s Bio: https://accessandaffordability.org/person/02-mackay-jimeson/

31 MAR 2023 · Even though 80% of the household decisions around health are made by women, only 4% of research and funding goes towards women’s health research. In today’s episode, https://www.linkedin.com/in/natalie-buford-young-55b10b/, Chief Executive Officer at https://sb.co/, joins us to discuss Springboard’s mission and how they are exploring a designated network to create pathways for emerging female innovators. We also get to hear about Natalie's experience testifying on the Hill to advocate for reducing the decline of women's entrepreneurship. Join us as we discuss: · Innovation in digital health and life sciences; · The Women's Health Innovation Coalition; and · Increasing diversity in clinical trials.

24 MAR 2023 · Runaway inflation and economic instability is terrible for just about everybody, but are efforts to tackle this problem creating more? To answer that, Kirsten Axelsen, Senior Policy Advisor at DLA Piper, joins the show to break down all the effects The Inflation Reduction act is having upon medicine, We discuss: - The potential negative impacts on small-molecule medicine - How the act affects patents and generic medicine - Why we may see declines in small-molecule medicine research

23 JAN 2023 · John was at the JP Morgan conference and is here to discuss the key takeaways of the Inflation Reduction Act: the small-molecule penalty, the value of small-molecule drugs, the importance of incentivizing post-approval research, intellectual property, and non-coverage decisions at CMS. You’ll also hear John’s take on the demand for a more pro-patient agenda. There was a lot of focus on the role of policy and government, specifically in relation to the inflation reduction act and its impact on the life science and venture capital industries. Ready to reaffirm its values, Incubate will be focusing its energy on working with the White House and Congress to make necessary amendments to the legislation. They’ll also have a focus on education and awareness to ensure that policymakers understand the critical role they play in the healthcare landscape. Join us as we discuss: - Why is there excitement for 2023 in the biotech sector, but also some anxiety? - How does the organization, Incubate, plan to address the inflation reduction act? - What Congress can be doing to create a more pro-patient agenda?

12 DEC 2022 · How will the Inflation Reduction Act affect life sciences startups, current and future revenues, and drug investment? What will happen to patients amidst the aftermath of unintended consequences? There aren’t too many people who know more about the ins and outs than the fine folks at DLA Piper. One of the biggest interventions in drug pricing since the Medicare Modernization Act was passed, listen to the inside scoop on what this means for the future of drugs. Join us as we discuss: -What drug price negotiations will look like under the act -How brand competition will play out -Which drugs and stakeholders will be affected

28 SEP 2022 · When you’re working to make good investments in bio and med tech there are three key pillars to consider: science, the management team and finance.  But how does it all come together in the end?  Find out in the latest episode with Christine Brennan, Managing Director, Vertex Venture HC as we talk about Vertex’s investment philosophy, why DEI inclusion is vital for industry, and what investments could look like for the rest of 2022. Join us as we discuss: Christine’s journey to becoming the Managing Director at Vertex The investment firm’s philosophy around Bio Tech, therapeutic investments and MedTech Why it’s so important for the next generation to have women in tech As we continue this journey together, we want to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what’s top of mind, what story you want to hear, or what you find interesting! To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

19 JUL 2022 · Everyone wants to make healthy choices. But we don't always have an opportunity to make healthy choices.  In today’s episode, we speak with Dr. Jerome Adams, Executive Director of Health Equity Initiatives at Purdue University and the 20th Surgeon General of the United States, about the need for proactive accessible health care, the economic burden of inaccessible healthcare, and why people need to know you care, before they care about what you know As we continue this journey together, we want to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what’s top of mind, what story you want to hear, or what you find interesting! To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.